Finnad­vance announces the indus­tri­al­iza­tion of its AKI­TA organ-on-chip plat­form

Finnad­vanced, a Life Sci­ence com­pa­ny from Oulu, is proud to announce the launch of their stan­dard­ized AKI­TA organ-on-chip plat­form.

About 5 years ago, the com­pa­ny shared a vision for replac­ing ani­mal test­ing in life sci­ence with New Approach Method­olo­gies using organ-on-chip tech­nolo­gies. Those are microflu­idic chips (not elec­tron­ic chips) that shape cells into organ-like archi­tec­ture aim­ing at more pre­cise mod­el­ing of human phys­i­ol­o­gy. The goal was to de-risk drug devel­op­ment by bet­ter pre­dict­ing the toxicity/efficacy of ther­a­pies devel­oped by the phar­ma­ceu­ti­cal indus­try.

The recent­ly launched AKI­TA organ-on-chip plat­form aims for:
• High­er through­put for the test of the high num­ber of drug com­pounds and cost reduc­tion
• Com­pat­i­ble with exist­ing equip­ment for easy imple­men­ta­tion in lab­o­ra­to­ry work­flows
• Price com­pet­i­tive for com­mon use in world­wide lab­o­ra­to­ries

More infor­ma­tion: www.akita.bio

Source: Finnad­vance